These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21917454)

  • 21. 5-Aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors.
    Gentile G; Merlo G; Pozzan A; Bernasconi G; Bax B; Bamborough P; Bridges A; Carter P; Neu M; Yao G; Brough C; Cutler G; Coffin A; Belyanskaya S
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1989-94. PubMed ID: 22310227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases.
    Maccallini C; Di Matteo M; Vullo D; Ammazzalorso A; Carradori S; De Filippis B; Fantacuzzi M; Giampietro L; Pandolfi A; Supuran CT; Amoroso R
    ChemMedChem; 2016 Aug; 11(16):1695-9. PubMed ID: 27377568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Replacing the cyclohexene-linker of FR181157 leading to novel IP receptor agonists: orally active prostacyclin mimetics. Part 6.
    Tanaka A; Hattori K; Taniguchi K; Okitsu O; Tabuchi S; Nishio M; Nagakura Y; Maeda N; Murai H; Seki J
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4861-4. PubMed ID: 16837197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro structure-activity relationship and in vivo characterization of 1-(aryl)-3-(4-(amino)benzyl)urea transient receptor potential vanilloid 1 antagonists.
    Perner RJ; DiDomenico S; Koenig JR; Gomtsyan A; Bayburt EK; Schmidt RG; Drizin I; Zheng GZ; Turner SC; Jinkerson T; Brown BS; Keddy RG; Lukin K; McDonald HA; Honore P; Mikusa J; Marsh KC; Wetter JM; George KS; Jarvis MF; Faltynek CR; Lee CH
    J Med Chem; 2007 Jul; 50(15):3651-60. PubMed ID: 17583335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and synthesis of 1-aryl-5-anilinoindazoles as c-Jun N-terminal kinase inhibitors.
    Jiang R; Frackowiak B; Shin Y; Song X; Chen W; Lin L; Cameron MD; Duckett DR; Kamenecka TM
    Bioorg Med Chem Lett; 2013 May; 23(9):2683-7. PubMed ID: 23518277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent Advances in Indazole-Containing Derivatives: Synthesis and Biological Perspectives.
    Zhang SG; Liang CG; Zhang WH
    Molecules; 2018 Oct; 23(11):. PubMed ID: 30373212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel series of indazole-/indole-based glucagon receptor antagonists.
    Lin S; Zhang F; Jiang G; Qureshi SA; Yang X; Chicchi GG; Tota L; Bansal A; Brady E; Trujillo M; Salituro G; Miller C; Tata JR; Zhang BB; Parmee ER
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4143-7. PubMed ID: 26303893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The discovery of novel cyclohexylamide CCR2 antagonists.
    Lanter JC; Markotan TP; Zhang X; Subasinghe N; Kang FA; Hou C; Singer M; Opas E; McKenney S; Crysler C; Johnson D; Molloy CJ; Sui Z
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7496-501. PubMed ID: 22061641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of novel azaindazole CCR1 antagonist clinical candidates.
    Harcken C; Kuzmich D; Cook B; Mao C; Disalvo D; Razavi H; Swinamer A; Liu P; Zhang Q; Kukulka A; Skow D; Patel M; Patel M; Fletcher K; Sherry T; Joseph D; Smith D; Canfield M; Souza D; Bogdanffy M; Berg K; Brown M
    Bioorg Med Chem Lett; 2019 Feb; 29(3):441-448. PubMed ID: 30595446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triazoloamides as potent γ-secretase modulators with reduced hERG liability.
    Fischer C; Zultanski SL; Zhou H; Methot JL; Shah S; Nuthall H; Hughes BL; Smotrov N; Hill A; Szewczak AA; Moxham CM; Bays N; Middleton RE; Munoz B; Shearman MS
    Bioorg Med Chem Lett; 2012 May; 22(9):3140-6. PubMed ID: 22497762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of a 4-Azetidinyl-1-thiazoyl-cyclohexane CCR2 Antagonist as a Development Candidate.
    Zhang X; Hou C; Hufnagel H; Singer M; Opas E; McKenney S; Johnson D; Sui Z
    ACS Med Chem Lett; 2012 Dec; 3(12):1039-44. PubMed ID: 24900425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Piperazinyl-3-sulfonylindazoles as potent and selective 5-hydroxytryptamine-6 antagonists.
    Liu KG; Robichaud AJ; Bernotas RC; Yan Y; Lo JR; Zhang MY; Hughes ZA; Huselton C; Zhang GM; Zhang JY; Kowal DM; Smith DL; Schechter LE; Comery TA
    J Med Chem; 2010 Nov; 53(21):7639-46. PubMed ID: 20932009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.
    Schaus JM; Thompson DC; Bloomquist WE; Susemichel AD; Calligaro DO; Cohen ML
    J Med Chem; 1998 May; 41(11):1943-55. PubMed ID: 9599243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An oxazolo[3,2-b]indazole route to 1H-indazolones.
    Oakdale JS; Solano DM; Fettinger JC; Haddadin MJ; Kurth MJ
    Org Lett; 2009 Jul; 11(13):2760-3. PubMed ID: 19505119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and hepatitis C antiviral activity of 1-aminobenzyl-1H-indazole-3-carboxamide analogues.
    Shi JJ; Ji FH; He PL; Yang YX; Tang W; Zuo JP; Li YC
    ChemMedChem; 2013 May; 8(5):722-5. PubMed ID: 23512654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel 2-aminooctahydrocyclopentalene-3a-carboxamides as potent CCR2 antagonists.
    Cai C; Kang FA; Hou C; O'Neill JC; Opas E; McKenney S; Johnson D; Sui Z
    Bioorg Med Chem Lett; 2013 Jan; 23(1):351-4. PubMed ID: 23182090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2,6-Diaryl-4-phenacylaminopyrimidines as potent and selective adenosine A(2A) antagonists with reduced hERG liability.
    Moorjani M; Zhang X; Chen Y; Lin E; Rueter JK; Gross RS; Lanier MC; Tellew JE; Williams JP; Lechner SM; Malany S; Santos M; Ekhlassi P; Castro-Palomino JC; Crespo MI; Prat M; Gual S; Díaz JL; Saunders J; Slee DH
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1269-73. PubMed ID: 18249540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and biological evaluation of substituted 2-cyclohexyl-4-phenyl-1H-imidazoles: potent and selective neuropeptide Y Y5-receptor antagonists.
    Blum CA; Zheng X; De Lombaert S
    J Med Chem; 2004 Apr; 47(9):2318-25. PubMed ID: 15084130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of phenyl piperidine derivatives as CCR2 antagonists.
    Xia M; Hou C; Pollack S; Brackley J; DeMong D; Pan M; Singer M; Matheis M; Olini G; Cavender D; Wachter M
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5964-8. PubMed ID: 17869105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potent heteroarylpiperidine and carboxyphenylpiperidine 1-alkyl-cyclopentane carboxamide CCR2 antagonists.
    Pasternak A; Goble SD; Vicario PP; Di Salvo J; Ayala JM; Struthers M; DeMartino JA; Mills SG; Yang L
    Bioorg Med Chem Lett; 2008 Feb; 18(3):994-8. PubMed ID: 18164199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.